NASDAQ:VIVE
Viveve Medical Inc Stock News
$0.0002
+0 (+0%)
At Close: Mar 28, 2024
18,168 Shares in Viveve Medical, Inc. (NASDAQ:VIVE) Purchased by Northern Trust Corp
09:38am, Tuesday, 07'th Dec 2021 Transcript Daily
Northern Trust Corp acquired a new position in shares of Viveve Medical, Inc. (NASDAQ:VIVE) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 18,168 shares of the companys stock, valued at approximately $54,000. Northern Trust Corp owned 0.17% of Viveve Medical []
Analyzing Yubo International Biotech (OTCMKTS:YBGJ) and Viveve Medical (NASDAQ:VIVE)
12:22am, Friday, 03'rd Dec 2021 Transcript Daily
Yubo International Biotech (OTCMKTS:YBGJ) and Viveve Medical (NASDAQ:VIVE) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, profitability, risk, institutional ownership, dividends, valuation and earnings. Risk & Volatility Yubo International Biotech has a beta of 6.22, indicating that its []
Contrasting Viveve Medical (NASDAQ:VIVE) and LivaNova (NASDAQ:LIVN)
12:20pm, Tuesday, 30'th Nov 2021 Transcript Daily
Viveve Medical (NASDAQ:VIVE) and LivaNova (NASDAQ:LIVN) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends. Valuation & Earnings This table compares Viveve Medical and LivaNovas revenue, earnings per share (EPS) and valuation. []
Viveve Medical (NASDAQ:VIVE) Lowered to Sell at Zacks Investment Research
11:46am, Thursday, 18'th Nov 2021 Transcript Daily
Zacks Investment Research cut shares of Viveve Medical (NASDAQ:VIVE) from a hold rating to a sell rating in a research report report published on Wednesday morning, Zacks.com reports. According to Zacks, Viveve Medical, Inc. is a medical device company focused on technologies for the cardiac and vascular markets. The Companys lead product, RenalGuard (R), is []
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q3 2021 Results - Earnings Call Transcript
08:45pm, Thursday, 11'th Nov 2021
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q3 2021 Results - Earnings Call Transcript
Viveve to Host Conference Call on November 11, 2021 to Report Third Quarter Financial Results and Provide Corporate Update
08:28am, Tuesday, 02'nd Nov 2021
ENGLEWOOD, CO / ACCESSWIRE / November 2, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it will report its third quart
Are Biotech Penny Stocks Worth Buying? Check These 3 Out
02:30pm, Monday, 20'th Sep 2021
Biotech penny stocks are heating up right now, here's three to watch The post Are Biotech Penny Stocks Worth Buying? Check These 3 Out appeared first on Penny Stocks to Buy, Picks, News and Informatio
Viveve to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
08:28am, Tuesday, 07'th Sep 2021
ENGLEWOOD, CO / ACCESSWIRE / September 7, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q2 2021 Results - Earnings Call Transcript
08:50pm, Thursday, 12'th Aug 2021
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q2 2021 Results - Earnings Call Transcript
Viveve Reports Second Quarter 2021 Financial Results and Provides Corporate Update
04:01pm, Thursday, 12'th Aug 2021
Total revenue of $1.7M reported for Q2 Reported sales of approximately 3,500 consumable treatment tips - a 42% unit increase quarter-over-quarter Pivotal SUI PURSUIT trial enrollment on-track for comp
VIVE Stock Price Increases Over 3% Pre-Market: Why It Happened
09:21am, Tuesday, 03'rd Aug 2021
The stock price of Viveve Medical Inc (NASDAQ: VIVE) increased by over 3% pre-market. This is why it happened.
Viveve Announces Continued Expansion of IP Portfolio with Issuance of Canadian Patent
08:28am, Tuesday, 03'rd Aug 2021
ENGLEWOOD, CO / ACCESSWIRE / August 3, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that the Canadian Intellectual Proper
Viveve to Participate in Ladenburg Thalmann Healthcare Virtual Conference
08:28am, Tuesday, 06'th Jul 2021
ENGLEWOOD, CO / ACCESSWIRE / July 6, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive offi
Viveve Announces Issuance of New Device and Methods Patent in U.S.
08:28am, Thursday, 10'th Jun 2021
ENGLEWOOD, CO / ACCESSWIRE / June 10, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that the United States Patent and Trad
Viveve Announces Adjournment of Annual Meeting
04:05pm, Wednesday, 02'nd Jun 2021
Meeting scheduled to reconvene June 23, 2021 at 12:00 PM Eastern Time Company encourages stockholders to cast their votes ENGLEWOOD, CO / ACCESSWIRE / June 2, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE)